Evidence map›Paper›PMID 39350125›Full record

ArticleBMC public health2024

Acceptance of COVID-19 vaccine booster doses among the Adult Population in Ghana: a cross-sectional study using the Health Belief Model.

Gilbert Eshun, Frank Kyei-Arthur, Marwa Shawky Abdou, Martin Wiredu Agyekum, Michael Sarfo, John Kwame Agbenyeavu, Sylvia Agyeman Addai, Jeremiah Akuffo Adjei, Nelson Obeng, Justice Kwadwo Turzin and 1 more

Abstract read
In one paragraph

Article in BMC public health, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Gilbert EshunSeventh-Day Adventist Hospital, Agona-Asamang, Ashanti Region, Ghana.
Frank Kyei-ArthurDepartment of Environment and Public Health, University of Environment and Sustainable Development, Somanya, Eastern Region, Ghana. fkyei-arthur@uesd.edu.gh.ORCID 0000-0001-9794-8524
Marwa Shawky AbdouDepartment of Epidemiology, High Institute of Public Health, Alexandria University, Alexandria, Egypt.
Martin Wiredu AgyekumInstitute for Educational Research and Innovation Studies, University of Education, Winneba, Central Region, Ghana.
Michael SarfoSchool of Human and Health Sciences, University of Huddersfield, Huddersfield, UK.
John Kwame AgbenyeavuMunicipal Health Directorate, Ghana Health Service - Krachi West, Kete-Krachi, Volta Region, Ghana.
Sylvia Agyeman AddaiDepartment of Science, Department of Educational Administration and Management, University of Education, Winneba, Central Region, Ghana.
Jeremiah Akuffo AdjeiUniversity of Ghana Medical Center, Legon-Accra, Greater Accra Region, Ghana.
Nelson ObengAhmadiyya Muslim Hospital, Techiman, Bono East Region, Ghana.
Justice Kwadwo TurzinDepartment of Biomedical Science, College of Health and Allied Sciences, University of Cape Coast, Cape Coast, Central Region, Ghana.
Ramy Mohamed GhazyFamily and Community Medicine, College of Medicine, King Khalid University, Abha, Asir Province, Saudi Arabia.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundThe Health Belief Model (HBM) is a widely utilised framework for understanding vaccination behaviour against COVID-19. This study assessed the acceptance of COVID-19 vaccine booster doses in Ghana and identified predictors using HBM domains, including perceived susceptibility, severity, benefits, barriers, self-efficacy, and cues to action. Additionally, it examined the sources of information about COVID-19 vaccines.

methodsWe employed a cross-sectional quantitative design, using convenient and snowball sampling methods to recruit participants. Between March 20 and May 10, 2023, 822 Ghanaians completed a predesigned self-administered online survey via commonly used social media platforms (WhatsApp, Facebook, X (Twitter), and LinkedIn). The study used a binary logistic regression to predict COVID-19 booster dose acceptance.

resultsThe respondents had a mean age of 29.3 ± 6.2, with 55.5 being males, 53.0% being single/never married, 93.7% having tertiary education, 83.0% being Christians, 59.1% were healthcare workers, 57.8% residing in urban areas, 95.5% having no chronic disease, 90.6% reporting negative COVID-19 history, and 78.3% reporting no reported relative/friend infected with COVID-19. The study showed that 81.1% [95% confidence interval (CI) = 78.4 - 83.8%] of respondents received the COVID-19 vaccine, and 58.3% [95% CI = 54.2 - 62.5%] of respondents were willing to accept the COVID-19 booster dose. The main reasons for non-acceptance of COVID-19 vaccine booster doses were personal reasons (41.7%) and experienced side effects or fear of side effects (32.4%). Regression analysis revealed that perceived benefits and perceived barriers (specifically worrying about serious risk factors) were the significant predictors of accepting COVID-19 booster doses in Ghana.

conclusionsMany respondents were willing to receive the COVID-19 booster dose. Personal reasons, fear of side effects, and experienced side effects were the main reasons for refusing COVID-19 booster doses. Perceived benefits and perceived barriers predicted COVID-19 booster dose acceptance in Ghana. Policymakers should consider these factors in designing public health interventions to increase the patronage of COVID-19 booster doses.

Indexed as

COVID-19COVID-19 VaccinesHealth Belief ModelImmunization, SecondaryAdolescentAdultCross-Sectional StudiesFemaleGhanaHumansMaleMiddle AgedPatient Acceptance of Health CareSurveys and QuestionnairesVaccination HesitancyYoung AdultCOVID-19 VaccinesBooster doseCOVID-19GhanaHealth belief modelVaccine hesitancy

Identifiers

PMID39350125
PMCPMC11440929

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.